Lv1
44 积分 2024-04-22 加入
Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression
1天前
待确认
Using RNA-seq to Assess Off-Target Effects of Antisense Oligonucleotides in Human Cell Lines
1个月前
已完结
Chemically Modified Platforms for Better RNA Therapeutics
3个月前
已完结
Bispecific, Exosome-Mimetic Lipid Nanoparticles Facilitate Dual siRNAs for Synergistic Therapy against Pancreatic Cancer
3个月前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
4个月前
已完结
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075
4个月前
已完结
Getting to HBV cure: The promising paths forward
5个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
5个月前
已完结
Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression
5个月前
已完结
An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients
5个月前
已完结
皖公网安备34019202002308
